To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TMEM115TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
198 representative clones for gene TMEM115 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AL554731 placenta, Placenta Cot 25-normalized .a 1 to 975 1 to 964   tiling clone,   964/990
(97 %)
20 diff
(98.0 %id)
TI_57215017   .a 46 to 713 53 to 720       668/721
(92 %)
3 diff
(99.6 %id)
CR605338 fetal liver .a 49 to 2111 1 to 2063 exact tiling clone,   2063/2063
(100 %)
0 diff
(100 %id)
AL531654 brain, fetal liver, Liver, neuroblastoma cells .a 49 to 973 1 to 913       913/914
(99 %)
17 diff
(98.2 %id)
AI815632 brain, frontal lobe .a 50 to 478 1 to 429       429/429
(100 %)
4 diff
(99.1 %id)
BI751996 brain .a 51 to 433 1 to 383       383/383
(100 %)
0 diff
(100 %id)
BG717858 testis .a 55 to 676 1 to 622       622/622
(100 %)
4 diff
(99.4 %id)
AK314166 synovial membrane tissue from rheumatoidarthritis .a 60 to 1567 1 to 1508 A14V     1508/1508
(100 %)
1 diff
(100.0 %id)
BP250597 hippocampus .a 60 to 636 1 to 576       576/582
(98 %)
11 diff
(98.2 %id)
DA972088 synovial membrane tissue from rheumatioidarthritis .a 61 to 620 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
AL534664 brain, fetal brain .a 65 to 1171 1 to 1088       1088/1097
(99 %)
33 diff
(97.0 %id)
AL550025 placenta, Placenta Cot 25-normalized .a 65 to 1076 1 to 1010       1010/1010
(100 %)
10 diff
(99.1 %id)
BY795902 eye .a 66 to 621 21 to 576       556/576
(96 %)
6 diff
(99.0 %id)
BG753819 eye, normal pigmented retinal epithelium .a 66 to 931 1 to 881       881/881
(100 %)
33 diff
(96.3 %id)
CF132208 Chondrosarcoma Lung Metastasis cell lines, lung .a 66 to 870 1 to 802       802/803
(99 %)
22 diff
(97.3 %id)
CR592998 Placenta Cot 25-normalized .a 67 to 2111 1 to 2045 exact     2045/2045
(100 %)
0 diff
(100 %id)
BX380937 Placenta Cot 25-normalized .a 67 to 1081 1 to 1005       1005/1016
(98 %)
22 diff
(97.9 %id)
AL551106 placenta, Placenta Cot 25-normalized .a 67 to 1059 1 to 984       984/1064
(92 %)
14 diff
(98.7 %id)
BF206032 muscle, rhabdomyosarcoma .a 67 to 659 1 to 592       592/592
(100 %)
2 diff
(99.7 %id)
BF305563 muscle, rhabdomyosarcoma .a 67 to 737 1 to 666       666/1150
(57 %)
15 diff
(98.7 %id)
BG762144 melanotic melanoma, high MDR (cell line), skin .a 67 to 858 1 to 794       794/799
(99 %)
3 diff
(99.7 %id)
BG763352 melanotic melanoma, high MDR (cell line), skin .a 67 to 649 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
CD243105 brain, Pituitary .a 67 to 864 1 to 804       804/865
(92 %)
9 diff
(99.0 %id)
NM_007024.4   .a 67 to 2161 1 to 2095 exact RefSeq, AAA   2095/2095
(100 %)
0 diff
(100 %id)
TI_159678053   .a 67 to 932 58 to 912       855/1101
(77 %)
27 diff
(97.6 %id)
BQ278178 ovary, teratocarcinoma, cell line .a 69 to 794 1 to 736       736/1155
(63 %)
24 diff
(98.0 %id)
BU553149 ovary, teratocarcinoma, cell line .a 69 to 710 1 to 646       646/1006
(64 %)
13 diff
(98.8 %id)
BU855457 ovary, teratocarcinoma, cell line .a 69 to 725 1 to 658       658/896
(73 %)
8 diff
(99.2 %id)
TI_57217928   .a 69 to 695 23 to 649       627/650
(96 %)
3 diff
(99.6 %id)
TI_57235992   .a 69 to 804 59 to 812       754/995
(75 %)
31 diff
(96.9 %id)
BX342087   .a 70 to 425 1 to 354       354/354
(100 %)
5 diff
(98.6 %id)
BF685651 leiomyosarcoma cell line, uterus .a 72 to 765 1 to 685       685/711
(96 %)
15 diff
(97.9 %id)
TI_57149155   .a 72 to 810 32 to 770       739/770
(95 %)
6 diff
(99.3 %id)
AL536579 brain, fetal brain .a 73 to 974 1 to 902       902/905
(99 %)
6 diff
(99.4 %id)
BX423666 brain, fetal brain .a 73 to 1059 1 to 983       983/1031
(95 %)
17 diff
(98.4 %id)
CR599068 HeLa cells Cot 25-normalized .a 74 to 2123 1 to 2050 exact     2050/2050
(100 %)
0 diff
(100 %id)
AL556101 placenta .a 74 to 1166 1 to 1091   fully sequenced,   1091/1091
(100 %)
15 diff
(98.7 %id)
BG395362 eye, retinoblastoma .a 75 to 811 8 to 744       737/1008
(73 %)
13 diff
(98.8 %id)
BM043454 carcinoma, cell line, Prostate .a 76 to 705 1 to 630       630/630
(100 %)
1 diff
(99.9 %id)
BM043809 carcinoma, cell line, Prostate .a 76 to 709 1 to 634       634/639
(99 %)
1 diff
(99.9 %id)
BM049103 carcinoma, cell line, Prostate .a 76 to 696 1 to 623       623/626
(99 %)
6 diff
(99.1 %id)
BU849643 ovary, teratocarcinoma, cell line .a 76 to 794 1 to 730       730/963
(75 %)
26 diff
(97.4 %id)
BI753298 brain .a 77 to 433 1 to 357       357/357
(100 %)
0 diff
(100 %id)
BI910007 leukocyte .a 77 to 433 1 to 361       361/361
(100 %)
6 diff
(98.4 %id)
BU502465 carcinoma, cell line, Prostate .a 77 to 893 13 to 836       824/942
(87 %)
19 diff
(98.0 %id)
CF242994 Brain glioblastoma .a 77 to 960 1 to 891       891/895
(99 %)
16 diff
(98.3 %id)
BQ070649 brain, neuroblastoma, cell line .a 78 to 801 1 to 726       726/1044
(69 %)
16 diff
(98.5 %id)
BQ188229 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 78 to 617 1 to 540       540/551
(98 %)
1 diff
(99.9 %id)
BI761589 pooled colon, kidney, stomach .a 80 to 433 1 to 354       354/354
(100 %)
0 diff
(100 %id)
CF132030 Chondrosarcoma Lung Metastasis cell lines, lung .a 81 to 815 1 to 732       732/735
(99 %)
6 diff
(99.2 %id)
TI_159677754   .a 81 to 964 51 to 917       867/1043
(83 %)
21 diff
(98.0 %id)
CN354551 embryonic stem cells, DMSO-treated H9 cellline .a 82 to 539 1 to 459       459/459
(100 %)
1 diff
(99.8 %id)
CN354552 embryonic stem cells, DMSO-treated H9 cellline .a 82 to 431 1 to 350       350/350
(100 %)
0 diff
(100 %id)
CR624062 B cells (Ramos cell line) Cot 25-normalized .a 82 to 2123 1 to 2042 exact     2042/2042
(100 %)
0 diff
(100 %id)
AL523287 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 82 to 1095 1 to 995   fully sequenced,   995/995
(100 %)
20 diff
(98.0 %id)
AL583035 B cells from Burkitt lymphoma .a 82 to 1102 1 to 1017   fully sequenced,   1017/1017
(100 %)
23 diff
(97.8 %id)
AL554006 placenta, Placenta Cot 25-normalized .a 84 to 1058 1 to 970   fully sequenced,   970/970
(100 %)
17 diff
(98.3 %id)
BG396189 eye, retinoblastoma .a 84 to 922 1 to 827       827/923
(89 %)
31 diff
(96.7 %id)
BM007676 Spleen .a 84 to 973 1 to 889       889/892
(99 %)
26 diff
(97.1 %id)
TI_59382909   .a 84 to 973 57 to 945       889/892
(99 %)
26 diff
(97.1 %id)
DA731218   .a 84 to 470 2 to 388   capped   387/387
(100 %)
1 diff
(99.8 %id)
AA338364 brain .a 86 to 254 1 to 168       168/168
(100 %)
1 diff
(99.5 %id)
BG281592 melanotic melanoma, skin .a 86 to 729 1 to 644       644/644
(100 %)
2 diff
(99.7 %id)
CF121179 CNCAP(3)T-225 cell line, Prostate .a 87 to 743 1 to 659       659/659
(100 %)
7 diff
(99.0 %id)
CN354550 embryonic stem cells, DMSO-treated H9 cellline .a 88 to 611 1 to 525       525/525
(100 %)
1 diff
(99.9 %id)
AL598928   .a 88 to 572 1 to 483       483/483
(100 %)
2 diff
(99.6 %id)
BE298731 muscle, rhabdomyosarcoma .a 88 to 667 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
CB265793 adipose .a 89 to 698 1 to 612       612/612
(100 %)
4 diff
(99.4 %id)
TI_159678033   .a 89 to 1161 51 to 1101       1051/1054
(99 %)
28 diff
(97.4 %id)
CF131860 Chondrosarcoma Lung Metastasis cell lines, lung .a 90 to 837 1 to 746       746/746
(100 %)
2 diff
(99.8 %id)
CX872138 embryonic stem .a 91 to 908 1 to 818       818/818
(100 %)
0 diff
(100 %id)
DR156161 human embryonic stem cells differentiated toan early endodermal cell type .a 91 to 750 1 to 660       660/660
(100 %)
0 diff
(100 %id)
AL527135 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 93 to 1058 1 to 958       958/1006
(95 %)
25 diff
(97.6 %id)
BX364534 Neuroblastoma Cot 25-normalized .a 93 to 1014 1 to 922       922/922
(100 %)
3 diff
(99.7 %id)
TI_57164100   .a 93 to 918 23 to 853       831/854
(97 %)
38 diff
(95.6 %id)
TI_154180184   .a 93 to 901 75 to 886       812/813
(99 %)
12 diff
(98.6 %id)
BU556511 ovary, teratocarcinoma, cell line .a 94 to 758 1 to 676       676/1004
(67 %)
28 diff
(97.3 %id)
BE409113 choriocarcinoma, placenta .a 95 to 750 1 to 667       667/667
(100 %)
13 diff
(98.1 %id)
BG329117 eye, retinoblastoma .a 95 to 828 1 to 733       733/734
(99 %)
19 diff
(97.5 %id)
BM043539 carcinoma, cell line, Prostate .a 95 to 730 1 to 636       636/637
(99 %)
1 diff
(99.9 %id)
BM046993 carcinoma, cell line, Prostate .a 95 to 784 1 to 689       689/691
(99 %)
2 diff
(99.8 %id)
CX762589 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 95 to 702 1 to 607     Submitted on the opposite strand 607/749
(81 %)
13 diff
(98.3 %id)
BE390054 endometrium, adenocarcinoma cell line, uterus .a 96 to 779 1 to 681       681/732
(93 %)
11 diff
(98.5 %id)
BE729583 melanotic melanoma, skin .a 96 to 898 1 to 817       817/1064
(76 %)
38 diff
(96.5 %id)
BF025839 melanotic melanoma, skin .a 96 to 831 1 to 741       741/882
(84 %)
23 diff
(97.4 %id)
BI834463 pooled pancreas and spleen .a 96 to 433 1 to 337       337/337
(100 %)
1 diff
(99.8 %id)
CN354547 embryonic stem cells, DMSO-treated H9 cellline .a 97 to 560 1 to 464       464/464
(100 %)
0 diff
(100 %id)
BG685194 B-cells, primary B-cells from tonsils (cell line) .a 97 to 827 1 to 731       731/731
(100 %)
4 diff
(99.5 %id)
BU541135 carcinoma, cell line, Prostate .a 97 to 890 1 to 804       804/838
(95 %)
10 diff
(98.9 %id)
CX166208 human embryonic stem cells differentiated toan early endodermal cell type .a 98 to 934 1 to 837       837/837
(100 %)
0 diff
(100 %id)
BI833031 pooled pancreas and spleen .a 102 to 433 1 to 332       332/332
(100 %)
0 diff
(100 %id)
TI_57168596   .a 102 to 829 59 to 788       730/957
(76 %)
7 diff
(99.3 %id)
BC011948 Brain, anaplastic oligodendroglioma with1p/19q loss .a 103 to 2161 1 to 2059 exact available from MGC, AAA   2059/2059
(100 %)
0 diff
(100 %id)
BE728142 melanotic melanoma, skin .a 106 to 902 1 to 789       789/1110
(71 %)
15 diff
(98.7 %id)
CF132028 Chondrosarcoma Lung Metastasis cell lines, lung .a 107 to 805 1 to 698       698/698
(100 %)
4 diff
(99.5 %id)
TI_159677752   .a 107 to 956 46 to 876       831/1002
(82 %)
28 diff
(97.3 %id)
BE736487 adenocarcinoma, Pancreas .a 108 to 922 1 to 815       815/1072
(76 %)
29 diff
(97.3 %id)
BM542384 melanotic melanoma, skin .a 110 to 803 5 to 710       706/1034
(68 %)
6 diff
(99.5 %id)
BC017367 Muscle, rhabdomyosarcoma .a 113 to 2154 1 to 2042 exact available from MGC, AAA   2042/2042
(100 %)
0 diff
(100 %id)
AL555121 placenta .a 113 to 871 1 to 756       756/756
(100 %)
6 diff
(99.3 %id)
CF132346 Chondrosarcoma Lung Metastasis cell lines, lung .a 126 to 916 1 to 788       788/790
(99 %)
6 diff
(99.3 %id)
TI_159676584   .a 126 to 1139 51 to 1052       1002/1079
(92 %)
22 diff
(98.0 %id)
CF132701 Chondrosarcoma Lung Metastasis cell lines, lung .a 150 to 877 1 to 727       727/727
(100 %)
3 diff
(99.6 %id)
TI_159677406   .a 150 to 1092 51 to 977       927/1069
(86 %)
23 diff
(97.9 %id)
BE382426 brain, neuroblastoma .a 153 to 850 1 to 692       692/692
(100 %)
9 diff
(98.7 %id)
CN354546 embryonic stem cells, cell lines H1, H7, andH9 .a 157 to 441 1 to 286       286/286
(100 %)
2 diff
(99.4 %id)
CN354548 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 157 to 391 1 to 235       235/235
(100 %)
0 diff
(100 %id)
BE728946 melanotic melanoma, skin .a 158 to 907 1 to 748       748/841
(88 %)
12 diff
(98.6 %id)
U09584 placenta .a 301 to 2159 1 to 1860 exact     1860/1860
(100 %)
4 diff
(99.8 %id)
BG281509 melanotic melanoma, skin .a 394 to 1332 1 to 924       924/936
(98 %)
41 diff
(95.7 %id)
CA394190 eye, RPE/choroid .a 443 to 912 1 to 470       470/470
(100 %)
2 diff
(99.6 %id)
TI_1948122732   .a 507 to 977 120 to 594   fully sequenced,   475/594
(79 %)
12 diff
(98.0 %id)
CR457020   .a 512 to 1567 1 to 1056 exact     1056/1056
(100 %)
1 diff
(100.0 %id)
CV025258 mixed .a 512 to 1131 1 to 620       620/620
(100 %)
0 diff
(100 %id)
BE887888 leiomyosarcoma, uterus .a 546 to 1221 1 to 682       682/1142
(59 %)
11 diff
(99.1 %id)
BX483116   .a 565 to 1174 1 to 610       610/610
(100 %)
0 diff
(100 %id)
AU141040   .a 601 to 1310 2 to 714   capped   713/714
(99 %)
14 diff
(98.1 %id)
BP252182 Kidney .a 622 to 1201 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BF514882   .a 623 to 1074 473 to 22       452/473
(95 %)
0 diff
(100 %id)
BM450138 melanotic melanoma, skin .a 638 to 1351 25 to 749       725/1172
(61 %)
20 diff
(98.3 %id)
CX788146 human embryonic stem cells .a 641 to 1395 1 to 755       755/755
(100 %)
1 diff
(99.9 %id)
BX453686 fetal liver, Liver .a 646 to 1514 882 to 1       882/955
(92 %)
35 diff
(96.4 %id)
BG818780 anaplastic oligodendroglioma with 1p/19qloss, brain .a 649 to 1440 23 to 813       791/813
(97 %)
16 diff
(98.1 %id)
BX431972 fetal liver, Liver .a 723 to 1603 1 to 883       883/883
(100 %)
12 diff
(98.7 %id)
BG420924 Kidney, renal cell adenocarcinoma .a 738 to 1472 1 to 728       728/961
(75 %)
23 diff
(97.7 %id)
BG820034 anaplastic oligodendroglioma with 1p/19qloss, brain .a 826 to 1376 1 to 554       554/554
(100 %)
8 diff
(98.6 %id)
BU155324 melanotic melanoma, cell line, skin .a 850 to 1717 1 to 874       874/875
(99 %)
14 diff
(98.4 %id)
BQ676278 melanotic melanoma, cell line, skin .a 850 to 1724 1 to 887       887/983
(90 %)
28 diff
(97.2 %id)
FN120722 breast carcinoma .a 867 to 950 85 to 1     Submitted on the opposite strand 85/86
(98 %)
1 diff
(98.9 %id)
BE833487 ovary .a 874 to 1119 248 to 2       247/252
(98 %)
0 diff
(100 %id)
BF983621 duodenal adenocarcinoma, cell line, small intestine .a 883 to 1511 1 to 629       629/629
(100 %)
3 diff
(99.6 %id)
CK819552 Islets of Langerhans, Pancreas .a 887 to 1467 1 to 581       581/582
(99 %)
7 diff
(98.8 %id)
BM129272 Islets of Langerhans, Pancreas .a 903 to 1410 1 to 509       509/509
(100 %)
3 diff
(99.5 %id)
BU846196 ovary, teratocarcinoma, cell line .a 904 to 1755 112 to 977       866/1099
(78 %)
37 diff
(96.7 %id)
BX283536 Kidney, renal carcinoma (ascites) .a 940 to 1456 1 to 517       517/517
(100 %)
1 diff
(99.9 %id)
BF445941 breast, invasive ductal carcinoma, 3 pooled samples .a 944 to 1654 714 to 3       712/714
(99 %)
23 diff
(96.8 %id)
TI_1948122733   .a 947 to 1566 743 to 124   fully sequenced,   620/743
(83 %)
2 diff
(99.8 %id)
AL576852 placenta, Placenta Cot 25-normalized .a 1028 to 2124 1083 to 1   fully sequenced,   1083/1083
(100 %)
19 diff
(98.3 %id)
AL523286 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1065 to 2106 1067 to 36   fully sequenced,   1032/1067
(96 %)
17 diff
(98.5 %id)
AL583034 B cells from Burkitt lymphoma .a 1072 to 2109 1040 to 12   fully sequenced,   1029/1040
(98 %)
12 diff
(98.9 %id)
AL573999 placenta, Placenta Cot 25-normalized .a 1080 to 2118 1034 to 6       1029/1054
(97 %)
11 diff
(99.0 %id)
BQ636103 eye, retina .a 1082 to 1663 1 to 582       582/582
(100 %)
0 diff
(100 %id)
AL574770 placenta, Placenta Cot 25-normalized .a 1087 to 2111 1019 to 1       1019/1055
(96 %)
20 diff
(98.2 %id)
BX423665 brain, fetal brain .a 1105 to 2119 1004 to 1       1004/1035
(97 %)
15 diff
(98.6 %id)
BX343480 Neuroblastoma Cot 25-normalized .a 1118 to 2122 1002 to 1       1002/1002
(100 %)
5 diff
(99.6 %id)
AL527123 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1120 to 2124 995 to 1       995/1021
(97 %)
26 diff
(97.5 %id)
BF339700 brain, glioblastoma with EGFR amplification .a 1124 to 1718 1 to 593       593/593
(100 %)
2 diff
(99.7 %id)
CD623590   .a 1130 to 1858 729 to 4       726/734
(98 %)
4 diff
(99.5 %id)
AL578515 placenta .a 1136 to 2121 984 to 5   fully sequenced,   980/984
(99 %)
5 diff
(99.5 %id)
BX362727   .a 1166 to 2129 963 to 1       963/967
(99 %)
24 diff
(97.6 %id)
AL564128 brain, fetal liver, Liver, neuroblastoma cells .a 1167 to 2111 936 to 1       936/961
(97 %)
18 diff
(98.2 %id)
AL577450 placenta, Placenta Cot 25-normalized .a 1173 to 2118 938 to 1       938/962
(97 %)
87 diff
(91.0 %id)
DA502797 brain .a 1174 to 1743 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
CD623588   .a 1206 to 1746 549 to 9       541/556
(97 %)
0 diff
(100 %id)
BF340655 brain, glioblastoma with EGFR amplification .a 1208 to 1835 1 to 625       625/626
(99 %)
5 diff
(99.3 %id)
AL565613 brain, fetal brain .a 1215 to 2124 906 to 1       906/983
(92 %)
9 diff
(99.1 %id)
TI_154127435   .a 1356 to 2152 882 to 94   AAA   789/982
(80 %)
17 diff
(98.3 %id)
BX374081   .a 1361 to 2157 801 to 1       801/932
(85 %)
25 diff
(97.4 %id)
AL577706 placenta .a 1363 to 2125 766 to 6       761/766
(99 %)
0 diff
(100 %id)
BU849662 ovary, teratocarcinoma, cell line .a 1392 to 2150 768 to 1     Submitted on the opposite strand 768/961
(79 %)
20 diff
(98.0 %id)
BX352492   .a 1397 to 2150 763 to 1       763/793
(96 %)
25 diff
(96.9 %id)
BE903528 choriocarcinoma, placenta .a 1398 to 2160 29 to 784       756/784
(96 %)
6 diff
(99.3 %id)
BU931126 ovary, teratocarcinoma, cell line .a 1405 to 2150 752 to 1     Submitted on the opposite strand 752/955
(78 %)
21 diff
(97.9 %id)
AA322909 brain, cerebellum .a 1507 to 1786 1 to 280       280/280
(100 %)
1 diff
(99.7 %id)
AA323108 brain, cerebellum .a 1507 to 1834 1 to 329       329/329
(100 %)
1 diff
(99.7 %id)
R46303 breast .a 1534 to 1904 1 to 378   fully sequenced,   378/378
(100 %)
8 diff
(97.9 %id)
TI_151743434   .a 1534 to 2128 66 to 660     Submitted on the opposite strand 595/1143
(52 %)
6 diff
(99.5 %id)
BU855792 ovary, teratocarcinoma, cell line .a 1555 to 2147 601 to 5     Submitted on the opposite strand 597/847
(70 %)
0 diff
(100 %id)
BU845377 ovary, teratocarcinoma, cell line .a 1558 to 2135 584 to 8     Submitted on the opposite strand 577/978
(58 %)
0 diff
(100 %id)
BM692371 eye, human retina .a 1582 to 2129 557 to 9     Submitted on the opposite strand 549/557
(98 %)
0 diff
(100 %id)
BU855719 ovary, teratocarcinoma, cell line .a 1588 to 2150 569 to 1     Submitted on the opposite strand 569/858
(66 %)
13 diff
(98.5 %id)
CA417128 Chondrosarcoma Cell line .a 1607 to 2152 564 to 19   AAA   546/546
(100 %)
0 diff
(100 %id)
CD370141 Alveolar Macrophage, lung .a 1609 to 2155 565 to 19   AAA   547/547
(100 %)
0 diff
(100 %id)
AA335695 epididymis .a 1611 to 1816 1 to 206       206/206
(100 %)
0 diff
(100 %id)
BM994890 lung, Lung Focal Fibrosis .a 1611 to 2155 563 to 19   AAA   545/545
(100 %)
0 diff
(100 %id)
BU620150 cell lines, Chondrosarcoma .a 1614 to 2161 566 to 19   AAA   548/548
(100 %)
0 diff
(100 %id)
BU633365 cell lines, Chondrosarcoma .a 1618 to 2154 555 to 19   AAA   537/537
(100 %)
0 diff
(100 %id)
BU618727 Cell Line, Chondrosarcoma .a 1620 to 2152 551 to 19   AAA   533/533
(100 %)
0 diff
(100 %id)
CA309470 Alveolar Macrophage, lung .a 1621 to 2159 557 to 19   AAA   539/539
(100 %)
0 diff
(100 %id)
AW583719 Islets of Langerhans, Pancreas .a 1626 to 2061 1 to 436       436/436
(100 %)
0 diff
(100 %id)
BQ006065 Chondrosarcoma, Left Pelvis .a 1629 to 2159 549 to 19   AAA   531/531
(100 %)
0 diff
(100 %id)
AI934503 anaplastic oligodendroglioma, brain .a 1636 to 2152 517 to 1       517/517
(100 %)
0 diff
(100 %id)
AI815908 brain, frontal lobe .a 1660 to 2159 510 to 11   AAA   500/500
(100 %)
3 diff
(99.4 %id)
AI125090 Spleen .a 1680 to 2157 480 to 3       478/480
(99 %)
0 diff
(100 %id)
AI570629 anaplastic oligodendroglioma, brain .a 1689 to 2154 466 to 1       466/466
(100 %)
0 diff
(100 %id)
AI075355 breast .a 1690 to 2158 469 to 1       469/469
(100 %)
0 diff
(100 %id)
BE207836 muscle, rhabdomyosarcoma .a 1693 to 2157 465 to 1       465/465
(100 %)
2 diff
(99.6 %id)
DB363321   .a 1697 to 2161 466 to 1       466/468
(99 %)
2 diff
(99.6 %id)
BG060097 brain, glioblastoma without EGFR amplification .a 1703 to 2153 451 to 1       451/451
(100 %)
4 diff
(99.2 %id)
AI361677 anaplastic oligodendroglioma, brain .a 1718 to 2152 435 to 1       435/435
(100 %)
0 diff
(100 %id)
AI857851 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1719 to 2152 434 to 1       434/434
(100 %)
0 diff
(100 %id)
AW769451 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 1719 to 2153 438 to 4       435/438
(99 %)
0 diff
(100 %id)
AI126678 uterus .a 1720 to 2149 432 to 3       430/432
(99 %)
0 diff
(100 %id)
AW028351 thymus, pooled .a 1721 to 2157 439 to 3       437/439
(99 %)
0 diff
(100 %id)
BE349909 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 1729 to 2157 432 to 5       428/432
(99 %)
0 diff
(100 %id)
AW593361 pooled .a 1735 to 2161 430 to 4       427/430
(99 %)
0 diff
(100 %id)
AW439207 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1743 to 2159 417 to 1       417/417
(100 %)
1 diff
(99.8 %id)
AW771191 colon, juvenile granulosa tumor .a 1744 to 2159 416 to 1       416/416
(100 %)
0 diff
(100 %id)
AW005180 anaplastic oligodendroglioma, brain .a 1765 to 2154 390 to 1       390/390
(100 %)
2 diff
(99.5 %id)
AA635916 normal prostate, Prostate .a 1787 to 2155 369 to 1       369/369
(100 %)
0 diff
(100 %id)
AA811115 germinal center B cell .a 1787 to 2101 312 to 1       312/312
(100 %)
3 diff
(99.1 %id)
AW070560 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .a 1793 to 2160 369 to 2       368/369
(99 %)
0 diff
(100 %id)
AW089414 brain, tumor, 5 pooled (see description) .a 1800 to 2162 372 to 9   tiling clone,   364/372
(97 %)
0 diff
(100 %id)
AI538276 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1808 to 2157 353 to 4       350/353
(99 %)
0 diff
(100 %id)
AI498931 anaplastic oligodendroglioma, brain .a 1830 to 2154 325 to 1       325/325
(100 %)
0 diff
(100 %id)
R46208 breast .a 1874 to 2152 280 to 1   fully sequenced,   280/280
(100 %)
0 diff
(100 %id)
AI864404 anaplastic oligodendroglioma, brain .a 1905 to 2153 250 to 2       249/250
(99 %)
0 diff
(100 %id)
AA456583 ovarian tumor, ovary .a 1957 to 2152 196 to 1       196/196
(100 %)
0 diff
(100 %id)
EH350843   .a 2039 to 2110 1 to 72       72/72
(100 %)
0 diff
(100 %id)
FN051176 breast carcinoma .a 2058 to 2150 1 to 93       93/93
(100 %)
0 diff
(100 %id)
FN099758 breast carcinoma .a 2064 to 2132 67 to 1     Submitted on the opposite strand 67/68
(98 %)
2 diff
(97.1 %id)
AI798511 ovary, tumor, 5 pooled (see description) .a 2071 to 2152 82 to 1       82/82
(100 %)
0 diff
(100 %id)
108 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA Expression Tissue Function, regulation, related genes C